SME Times News Bureau | 07 May, 2021
Reliance Industries (RIL) has sought permission to fly a team of experts
from Israel to India to train and install a rapid Covid-19
identification solution, a source who spoke on assurance of anonymity
said.
Reliance signed the deal in January this year with Breath
of Health (BOH) to distribute the firm's swift Covid-19 breath testing
system. The system developed by Israeli medical technology company
identifies coronavirus carriers and patients in the early stages of the
disease by exhalation and the results will be available within seconds. A
mail sent to RIL remained unanswered.
Reliance signed a $15
million deal with Israeli company Breath of Health (BOH) to distribute
the company's swift Covid-19 breath testing system in India.
According
to the agreement, RIL will purchase hundreds of systems from the
Israeli company in a deal valued at $15 million and will use them to
conduct millions of tests a month at a cost of $ 10 million per month
BOH is said to have developed a breath test system that identifies Covid-19 at a success rate of over 95 per cent.
Business
portal Calcalist reported that B.O.H developed a breath test system
that identifies Covid-19 at a success rate of over 95 per cent.
Preliminary results from clinical trials it is conducting with Israeli
hospitals Hadassah Medical Center and the Sheba Medical Center at Tel
HaShomer have shown a success rate of 98% compared to the standard PCR
test authorized by global medical organizations.
The development
of B.O.H's system began two years ago and was initially meant to
provide early detection for cancer, Alzheimer's, and lung disease. The
company's scientists decided to focus on adapting the system to detect
Covid-19 following the outbreak of the pandemic, recognizing that it
could be a crucial tool in the fight against the virus until the arrival
of the vaccines, the report said.
B.O.H CEO Arie Laor said that
the company had operated under the radar to date in order to focus on
its clinical trials and the development of its system. Laor added that
the agreement will help to accelerate the trials and that he is
expecting results to be announced in the coming weeks.
